The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

New test to determine malignancy of a nodule

sjde
sjde CSN Member Posts: 10
edited March 2014 in Thyroid Cancer #1
Has anyone had this new molecular test to determine if a nodule is benign or malignant prior to surgery? It looks like it could prevent many surgeries when a nodule is suspicious for follicuar/Hurthle cell cancer after a biopsy. Dr Bryan Haugen of U. of CO Hospital presented findings last month after a thyroid conference in Paris.

http://www.medicalnewstoday.com/articles/201254.php

Sue
Like Care

Discussion Boards